L-Alanyl/L-Glutamine

DRUG2 trials

Sponsors

Temple Therapeutics BV, University Hospital Muenster

Conditions

Acute Kidney InjuryCardiac SurgeryPelvic Adhesions

Phase 1

A Clinical Study of Alanyl-Glutamine for Reduction of Post-Myomectomy Adhesions

CompletedNCT01701193

Temple Therapeutics BVPelvic Adhesions

Start: 2015-02-15End: 2016-10-20Updated: 2021-05-07

Phase 3

Reduction of Occurence of Acute Kidney Injury (AKI) Through Administration of Glutamine

CompletedNCT04019184

University Hospital MuensterAcute Kidney Injury, Cardiac Surgery

Start: 2019-07-18End: 2020-05-13Updated: 2020-05-21